The endocannabinoid system in gp120-mediated insults and HIV-associated dementia

[1]  D. Centonze,et al.  The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis , 2010, Experimental Neurology.

[2]  R. Mechoulam,et al.  Novel natural and synthetic ligands of the endocannabinoid system. , 2010, Current medicinal chemistry.

[3]  M. Pistis,et al.  From surface to nuclear receptors: the endocannabinoid family extends its assets. , 2010, Current medicinal chemistry.

[4]  A. Howlett,et al.  CB(1) cannabinoid receptors and their associated proteins. , 2010, Current medicinal chemistry.

[5]  V. D. M. A. L. D. Petrocellis.  Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs. , 2010 .

[6]  Q. Pittman,et al.  Cannabinoid CB2 Receptors in Health and Disease , 2010 .

[7]  Christian Steinhäuser,et al.  Astrocyte dysfunction in epilepsy , 2010, Brain Research Reviews.

[8]  R. Pertwee.  Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. , 2010, Current medicinal chemistry.

[9]  Giorgio Carmignoto,et al.  Glutamate‐mediated astrocyte‐to‐neuron signalling in the rat dorsal horn , 2010, The Journal of physiology.

[10]  N. Stella.  Endocannabinoid signaling in microglial cells , 2009, Neuropharmacology.

[11]  Í. Azcoitia,et al.  Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. , 2009, Brain : a journal of neurology.

[12]  C. Salata,et al.  Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia , 2009, Journal of NeuroVirology.

[13]  M. Churchill,et al.  Extensive astrocyte infection is prominent in human immunodeficiency virus–associated dementia , 2009, Annals of neurology.

[14]  G. Perea,et al.  Tripartite synapses: astrocytes process and control synaptic information , 2009, Trends in Neurosciences.

[15]  V. Marzo,et al.  The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. , 2009, Pharmacological research.

[16]  H. Xiong,et al.  Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. , 2009, Life sciences.

[17]  A. Finazzi-Agro’,et al.  Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. , 2009, Chemistry & biology.

[18]  S. Petrosino,et al.  From endocannabinoid profiling to 'endocannabinoid therapeutics'. , 2009, Current opinion in chemical biology.

[19]  J. Bhattacharya,et al.  Cellular & molecular basis of HIV-associated neuropathogenesis. , 2009, The Indian journal of medical research.

[20]  D. Ferreira,et al.  Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications. , 2009, Recent patents on CNS drug discovery.

[21]  Honghong Yao,et al.  HIV-1 Tat Co-Operates with IFN-γ and TNF-α to Increase CXCL10 in Human Astrocytes , 2009, PloS one.

[22]  E. Eng,et al.  "It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting. , 2009, Social science & medicine.

[23]  G. Bernardi,et al.  Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway , 2009, The Journal of Neuroscience.

[24]  J. Fernández-Ruiz.  The endocannabinoid system as a target for the treatment of motor dysfunction , 2009, British journal of pharmacology.

[25]  O. Arancio,et al.  Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. , 2009, Mini reviews in medicinal chemistry.

[26]  B. Aggarwal,et al.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. , 2009, Trends in pharmacological sciences.

[27]  H. Budka,et al.  Reduced Expression of Excitatory Amino Acid Transporter 2 and Diffuse Microglial Activation in the Cerebral Cortex in AIDS Cases With or Without HIV Encephalitis , 2009, Journal of neuropathology and experimental neurology.

[28]  T. Fellin,et al.  Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity , 2009, Journal of neurochemistry.

[29]  A. Makriyannis,et al.  Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells1 , 2008, The Journal of Immunology.

[30]  G. Cabral,et al.  Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. , 2008, Endocrine, metabolic & immune disorders drug targets.

[31]  P. Massi,et al.  Expression and function of the endocannabinoid system in glial cells. , 2008, Current pharmaceutical design.

[32]  I. Galve-Roperh,et al.  Mechanisms of control of neuron survival by the endocannabinoid system. , 2008, Current pharmaceutical design.

[33]  D. Centonze,et al.  The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. , 2008, Current pharmaceutical design.

[34]  S. Tauber,et al.  CNS immune surveillance and neuroinflammation: endocannabinoids keep control. , 2008, Current pharmaceutical design.

[35]  C. Hillard.  Role of cannabinoids and endocannabinoids in cerebral ischemia. , 2008, Current pharmaceutical design.

[36]  Corrado Calì,et al.  SDF 1-alpha (CXCL12) triggers glutamate exocytosis from astrocytes on a millisecond time scale: Imaging analysis at the single-vesicle level with TIRF microscopy , 2008, Journal of Neuroimmunology.

[37]  B. Alger,et al.  Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus , 2008, Proceedings of the National Academy of Sciences.

[38]  S. Buch,et al.  Roles of MCP-1 in development of HIV-dementia. , 2008, Frontiers in bioscience : a journal and virtual library.

[39]  B. Cravatt,et al.  Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain* , 2008, Journal of Biological Chemistry.

[40]  L. Marnett,et al.  Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids* , 2008, Journal of Biological Chemistry.

[41]  Sufen Yang,et al.  Curcumin Protects Dopaminergic Neuron Against LPS Induced Neurotoxicity in Primary Rat Neuron/Glia Culture , 2008, Neurochemical Research.

[42]  K. Mackie,et al.  GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current , 2008, Proceedings of the National Academy of Sciences.

[43]  E. Dainese,et al.  Evidence for the intracellular accumulation of anandamide in adiposomes , 2008, Cellular and Molecular Life Sciences.

[44]  H. V. Gersdorff,et al.  Endocannabinoids Mediate Synaptic Plasticity at Mixed Synapses , 2007, Neuron.

[45]  J. Romero,et al.  The Endocannabinoid System and Alzheimer’s Disease , 2007, Molecular Neurobiology.

[46]  B. Martin,et al.  WIN55,212-2-Mediated Inhibition of HIV-1 Expression in Microglial Cells: Involvement of Cannabinoid Receptors , 2007, Journal of Neuroimmune Pharmacology.

[47]  D. Centonze,et al.  The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases , 2007, Progress in Neurobiology.

[48]  D. Centonze,et al.  The endocannabinoid system in targeting inflammatory neurodegenerative diseases. , 2007, Trends in pharmacological sciences.

[49]  E. Cudaback,et al.  Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells , 2007, The Journal of Neuroscience.

[50]  K. Ng,et al.  HIV-1 protein gp120 rapidly impairs memory in chicks by interrupting the glutamate–glutamine cycle , 2007, Neurobiology of Learning and Memory.

[51]  Bharat B. Aggarwal,et al.  “Spicing Up” of the Immune System by Curcumin , 2007, Journal of Clinical Immunology.

[52]  Howard E Gendelman,et al.  HIV-1 gp120 Compromises Blood–Brain Barrier Integrity and Enhance Monocyte Migration across Blood–Brain Barrier: Implication for Viral Neuropathogenesis , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  W. Banks,et al.  A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells , 2006, Experimental Neurology.

[54]  I. Lizasoain,et al.  Characterization of the Neuroprotective Effect of the Cannabinoid Agonist WIN-55212 in an In Vitro Model of Hypoxic-Ischemic Brain Damage in Newborn Rats , 2006, Pediatric Research.

[55]  Vivien Chevaleyre,et al.  Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.

[56]  R. Mechoulam,et al.  The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines , 2006, Neurobiology of Disease.

[57]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-α , 2006, Nature.

[58]  T. Möller,et al.  Microglia Biology in Health and Disease , 2006, Journal of Neuroimmune Pharmacology.

[59]  R. Bertorelli,et al.  CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms , 2006, The European journal of neuroscience.

[60]  R. Nitsch,et al.  The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells , 2006, Neuron.

[61]  E. Ponomarev,et al.  Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli , 2005, Journal of neurochemistry.

[62]  B. Cravatt,et al.  Structure and function of fatty acid amide hydrolase. , 2005, Annual review of biochemistry.

[63]  J. Romero,et al.  Functional neuroanatomy of the endocannabinoid system , 2005, Pharmacology Biochemistry and Behavior.

[64]  W. Banks,et al.  HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells , 2005, Brain Research.

[65]  D. Osei-Hyiaman,et al.  Evidence for novel cannabinoid receptors. , 2005, Pharmacology & therapeutics.

[66]  S. Gaetani,et al.  Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation , 2005, Journal of Pharmacology and Experimental Therapeutics.

[67]  M. Mattson,et al.  Cell death in HIV dementia , 2005, Cell Death and Differentiation.

[68]  K. Mackie,et al.  A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis , 2005, The Journal of Neuroscience.

[69]  R. Nosheny,et al.  Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration , 2005, Neurotoxicity Research.

[70]  M. L. de Ceballos,et al.  Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation , 2005, The Journal of Neuroscience.

[71]  G. Kroemer,et al.  Mechanisms of apoptosis induction by the HIV-1 envelope , 2005, Cell Death and Differentiation.

[72]  Shuxian Hu,et al.  Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes , 2005, Glia.

[73]  Udaykumar Ranga,et al.  Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription* , 2004, Journal of Biological Chemistry.

[74]  A. Barbáchano,et al.  Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study , 2004, Synapse.

[75]  A. Finazzi-Agro’,et al.  Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV‐1 coat glycoprotein gp120 in the rat neocortex , 2004, Journal of neurochemistry.

[76]  W. Campbell,et al.  Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. , 2004, Molecular pharmacology.

[77]  G. Buzsáki,et al.  Calcium Dynamics of Cortical Astrocytic Networks In Vivo , 2004, PLoS biology.

[78]  T. Möller,et al.  P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[79]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[80]  P. Peterson,et al.  Cannabinoids and morphine differentially affect HIV-1 expression in CD4+ lymphocyte and microglial cell cultures , 2004, Journal of Neuroimmunology.

[81]  M. Mattson,et al.  Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia , 2004, Annals of neurology.

[82]  Gareth Williams,et al.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.

[83]  M. Eder,et al.  CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.

[84]  N. Stella,et al.  Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. , 2003, European journal of pharmacology.

[85]  N. Rothwell,et al.  Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia , 2003, The Journal of Neuroscience.

[86]  T. Groblewski,et al.  Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models , 2003, The European journal of neuroscience.

[87]  K. Mackie,et al.  Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration , 2003, The Journal of Neuroscience.

[88]  E. Del Giudice,et al.  Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide , 2003, Glia.

[89]  T. Bisogno,et al.  The Endocannabinoid System Protects Rat Glioma Cells Against HIV-1 Tat Protein-induced Cytotoxicity , 2002, The Journal of Biological Chemistry.

[90]  K. Nicolay,et al.  Acute neuronal injury, excitotoxicity, and the endocannabinoid system , 2002, Molecular Neurobiology.

[91]  H. Xiong,et al.  HIV‐1‐Associated Dementia: A Metabolic Encephalopathy Perpetrated by Virus‐Infected and Immune‐Competent Mononuclear Phagocytes , 2002, Journal of acquired immune deficiency syndromes.

[92]  P. Calabresi,et al.  Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission , 2002, The Journal of Neuroscience.

[93]  A. Finazzi-Agro’,et al.  Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. , 2002, Journal of medicinal chemistry.

[94]  T. Möller,et al.  Astrocytes in Culture Produce Anandamide and Other Acylethanolamides* , 2002, The Journal of Biological Chemistry.

[95]  David Julius,et al.  Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers , 2002, Cell.

[96]  K. Waku,et al.  Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[97]  Beat Lutz,et al.  Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1 , 2002, Journal of neurochemistry.

[98]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[99]  R. Nisticò,et al.  Exploitation of the HIV‐1 coat glycoprotein, gp120, in neurodegenerative studies in vivo , 2001, Journal of neurochemistry.

[100]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[101]  C. Newton,et al.  Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. , 2001, European journal of pharmacology.

[102]  H. Gendelman,et al.  Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages , 2001, Journal of Neuroimmunology.

[103]  Stuart A. Lipton,et al.  Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.

[104]  D. Deutsch,et al.  The fatty acid amide hydrolase (FAAH). , 2000, Prostaglandins, leukotrienes, and essential fatty acids.

[105]  O. Prospero-Garcia,et al.  HIV- and FIV-Derived gp120 Alter Spatial Memory, LTP, and Sleep in Rats , 2000, Neurobiology of Disease.

[106]  G. Nisticó,et al.  gp120 Induces Cell Death in Human Neuroblastoma Cells Through the CXCR4 and CCR5 Chemokine Receptors , 2000, Journal of neurochemistry.

[107]  D. Linden,et al.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[108]  J. W. Rudy,et al.  Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments , 2000, Brain Research.

[109]  C. Murdoch,et al.  Chemokine Receptors and Their Role in Vascular Biology , 2000, Journal of Vascular Research.

[110]  Gerald Maguire,et al.  Expression of CB2 cannabinoid receptor mRNA in adult rat retina , 2000, Visual Neuroscience.

[111]  R. Floyd.  Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[112]  B. Cravatt,et al.  Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. , 1999, Biochemistry.

[113]  M. Kaul,et al.  Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[114]  G. Cabral,et al.  The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. , 1999, The Journal of pharmacology and experimental therapeutics.

[115]  S. Hwang,et al.  Capsaicin Binds to the Intracellular Domain of the Capsaicin-Activated Ion Channel , 1999, The Journal of Neuroscience.

[116]  S. Galiègue,et al.  Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. , 1998, Blood.

[117]  W. Kelder,et al.  β‐Chemokines MCP‐1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus–associated dementia , 1998 .

[118]  M. Nedergaard,et al.  Cytoskeletal Assembly and ATP Release Regulate Astrocytic Calcium Signaling , 1998, The Journal of Neuroscience.

[119]  G. Nisticó,et al.  Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade. , 1998, The Biochemical journal.

[120]  D. Piomelli,et al.  A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.

[121]  F. Silverstein,et al.  gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats , 1997, Neuroscience.

[122]  Stephen P. Mayfield,et al.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.

[123]  L. Mucke,et al.  Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine , 1996, Brain Research.

[124]  J. Merrill,et al.  Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain , 1995, The Journal of experimental medicine.

[125]  J. Schwartz,et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.

[126]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[127]  D. Brenneman,et al.  HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates , 1993, Brain Research.

[128]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[129]  L. Panlilio,et al.  Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist , 1992, Brain Research.

[130]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[131]  S. Lipton,et al.  HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. , 1990, Science.

[132]  M. Maccarrone.  16 The Endocannabinoid System and its Manifold Central Actions , 2009 .

[133]  A. Lajtha,et al.  Handbook of neurochemistry and molecular neurobiology : Neural lipids , 2009 .

[134]  F. Fezza,et al.  Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. , 2008, Sub-cellular biochemistry.

[135]  F. Helmchen,et al.  Imaging cellular network dynamics in three dimensions using fast 3D laser scanning , 2007, Nature Methods.

[136]  A. Troncoso,et al.  Regional differences in astrocyte activation in HIV-associated dementia. , 2006, Medicina.

[137]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-alpha. , 2006, Nature.

[138]  V. Marzo.  Endocannabinoids: synthesis and degradation. , 2006 .

[139]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[140]  S. Gaetani,et al.  Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.

[141]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. , 2003, Nature medicine.

[142]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[143]  J. Ludovic Croxford,et al.  Therapeutic Potential of Cannabinoids in CNS Disease , 2003, CNS drugs.

[144]  G. Cabral,et al.  Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. , 2002, International immunopharmacology.

[145]  A. Volterra,et al.  Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. , 2001, Progress in brain research.

[146]  G. Cabral,et al.  Cannabinoids inhibit LPS‐inducible cytokine mRNA expression in rat microglial cells , 2000, Glia.

[147]  D. Kolson,et al.  HIV and HIV dementia. , 2000, The Journal of clinical investigation.

[148]  E. Bahraoui,et al.  Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. , 1998, Research in virology.

[149]  P. Portegies.  AIDS dementia complex: a review. , 1994, Journal of acquired immune deficiency syndromes.

[150]  K. Mackie,et al.  Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .